We're counting down to the 10th Annual World Medical Innovation Forum, happening September 23-25 in Boston. With less than 2 months to go, now is the perfect time to secure your spot for this premier healthcare innovation event. Join us to connect with industry leaders, top Harvard faculty, investors, analysts, deal makers, entrepreneurs, FDA leaders, and payers in a premier setting. https://lnkd.in/emj7fsdW Don't miss out – register today to ensure your place at the forefront of medical innovation! 🔗 Register Here: https://lnkd.in/eXsybx2X #WMIF2024 #Innovation #HealthcareInnovation #Networking #BostonEvents
Mass General Brigham Innovation
Hospitals and Health Care
Cambridge, MA 8,797 followers
Advancing the inventions and commercial applications of Mass General Brigham’s 74,000 employees.
About us
Mass General Brigham Innovation has responsibility for the commercial application of the assets and capabilities of the academic medical centers of Mass General Brigham, including Brigham and Women’s Hospital, Massachusetts General Hospital, McLean Hospital and Massachusetts Eye and Ear. Mass General Brigham is the largest academic research enterprise in the US. Bringing together specialists in technology licensing, research contracts, ventures and business development, Innovation partners with investigators, scientists and clinicians to translate innovations into healthcare practice via a variety of business channels. In 2014, Partners HealthCare, now known as Mass General Brigham, was named as one of the "World's Top 10 Most Innovative Companies in Health Care" by Fast Company.
- Website
-
https://massgeneralbrigham.org/innovation
External link for Mass General Brigham Innovation
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, MA
- Type
- Nonprofit
- Specialties
- Collaborative Innovation, Business Development, Commercialization, and Medical Devices
Locations
-
Primary
215 First Street, Suite 500
Cambridge, MA 02141, US
Employees at Mass General Brigham Innovation
-
Roger Kitterman
Managing Partner, Mass General Brigham Ventures
-
Patrice Hollinger MBA, SHRM-CP
-
Margie Coloian
Mass General Brigham Innovation
-
Liz Kwo MD, MBA, MPH
Health Tech Executive | Board Director | Physician | Author of Digital MD | Faculty Lecturer @ Harvard Medical School |
Updates
-
Exciting insights from Dr. Brittany Weber at the 2023 World Medical Innovation Forum! As a cardiologist with a deep interest in cardio rheumatology, Weber discusses the intersection of inflammatory diseases and heart health, stressing the need for continuous innovation to drive scientific discoveries and enhance patient outcomes. She advocates for collaboration among diverse stakeholders—scientists, clinicians, and industry experts—to solve the complex challenges faced in her field. Don’t miss your chance to join the conversation at the 10th Annual World Medical Innovation Forum! Join us at the five-star Encore Boston Harbor Hotel from September 23-25 to connect with the experts driving healthcare #innovation. Hosted by Mass General Brigham and Bank of America, #WMIF2024 provides unparalleled opportunities to engage with top CEOs, Harvard faculty, investors, and government officials, all dedicated to reshaping #healthcare. Register today: https://lnkd.in/eXsybx2X
-
Is #DigitalHealth investment and partnerships on the rise or decline? Gaye Bok, Partner, AI and Digital Innovation Fund, Mass General Brigham, will join other #healthinnovation leaders in the panel "Digital Health 2024: Have We Turned a Corner?" to explore the economics and outline how #AI, #ChatGPT, and #LLMs are changing the landscape. Don't miss it! Wednesday, July 24, at 11:00 AM Eastern time. Register now: https://lnkd.in/gRnMpQZQ
-
-
Mass General Brigham Innovation reposted this
Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program, and Bryan Choi, MD, PhD, associate director of Brain Tumor Immunology and Immunotherapy, are changing the way glioblastoma is treated with a next generation CAR T therapy research study. They are infusing genetically modified white blood cells directly into the fluid surrounding the brain. The second patient in the trial, Tom Fraser from upstate New York, was given just six months to live before he was introduced to the trial. It has now been almost three years since his initial diagnosis. Read more about the trial and Tom's story from New York Magazine: http://spklr.io/6040SsK6
-
Hear Laura Germine, PhD, discuss the potential of digital technology to bridge the gap between the demand and supply of mental health services globally, improving patient outcomes and accessibility. In this onsite interview at the 2023 World Medical Innovation Forum, Germine emphasizes the urgent need for innovation in mental health care and explores how digital technology can address the severe disparity in mental health services. https://lnkd.in/eg_XkeeJ Be sure to attend the 2024 World Medical Innovation Forum for more insights from top innovators and current developments in mental health. Join Mass General Brigham and Bank of America to explore the latest advancements in healthcare innovation, September 23-25 at the Encore Boston Harbor. Register here: https://lnkd.in/eXsybx2X
Laura Germine, PhD, discusses the global impact of mental health care innovation at #WMIF2023
https://www.youtube.com/
-
Mass General Brigham Innovation reposted this
We’ve seen so much enthusiasm & dedication to advancing women's health! 💖While we await the announcement of the #SprintForWomensHealth awards later this year, Sprint for Women’s Health lead Dr. Jenica Patterson shares ways you can still engage with us. These opportunities include: 💡Mission Office ISOs 💡SBIRs 💡ARPANET-H 💡PM application https://lnkd.in/eRpS4N7v
-
Mass General Brigham Innovation reposted this
Congrats to MGBV portfolio company, Nocion Therapeutics, Inc., on expansion of their SAB and leadership team in preparation for their ASPIRE (Ph 2b) clinical trial for chronic cough.
We are delighted to welcome Catherine Bonuccelli and Joan Shaw to Nocion. Read the full press release here: https://lnkd.in/er6bZCHW
-
-
Join Mass General Brigham’s top Harvard faculty and Bank of America’s leading equity research team at the World Medical Innovation Forum. Explore cutting-edge healthcare innovations and meet the people driving these advancements. Secure your spot now! Register today for the 10th Annual World Medical Innovation Forum, from September 23-25 in Boston. https://lnkd.in/eXsybx2X #WMIF2024 #Innovation #HealthcareInnovation
2024 World Medical Innovation Forum
https://2024.worldmedicalinnovation.org
-
MESH Core 2024 brought together over 300 innovators from 10 countries for an intensive, hands-on healthcare innovation bootcamp. Led by Marc Succi, MD, the two-day event featured keynotes, panels, and workshops on AI, digital health, and emerging technologies, fostering collaboration and networking among participants. Read the full recap here: https://lnkd.in/eKMsg6rC Follow us and the MESH Incubator | Mass General Brigham for updates on MESH Core 2025 and join us in advancing healthcare innovation. #Innovation #HealthcareInnovation #MESHCore #MedTech #HealthTech
Everything You Need to Know About MESH Core 2024
massgeneralbrigham.org
-
In this onsite interview at the 2023 World Medical Innovation Forum, Keith Flaherty, MD, Director of Clinical Research at Mass General Cancer Center, discusses the integration of scientific discovery and clinical practice in cancer therapy development. He highlights the critical importance of collaboration among doctors, patients, biotech companies, pharmaceutical firms, venture investors, and regulators in this process. https://lnkd.in/gMNdQ_eJ Be sure to attend the 2024 World Medical Innovation Forum September 23 – 25, where Dr. Flaherty will discuss "Oncology’s New Paradigm," sharing the latest advancements in immunotherapy, precision medicine, and early detection techniques that are revolutionizing cancer treatment and shaping the future of oncology care. Register today at https://lnkd.in/gbffVa_d #WMIF2024 #Innovation #HealthcareInnovation #Oncology #CancerCare
Keith Flaherty, MD, Director of Clinical Research at Mass General Cancer Center, speaks at #WMIF2023
https://www.youtube.com/